| HGNC Family | Phosphatases |
| Name | protein phosphatase, Mg2+/Mn2+ dependent, 1L |
| Description | The protein encoded by this gene is a magnesium or manganese-requiring phosphatase that is involved in several signaling pathways. The encoded protein downregulates apoptosis signal-regulating kinase 1, a protein that initiates a signaling cascade that leads to apoptosis when cells are subjected to cytotoxic stresses. This protein also is an endoplasmic reticulum transmembrane protein that helps regulate ceramide transport from the endoplasmic reticulum to the Golgi apparatus. Finally, this gene may be involved in adiposity since it is upregulated in adipose tissues. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nAlthough none of the provided abstracts directly study PPM1L, they collectively illustrate the crucial importance of negative regulation in the TGF‑β/Smad signaling pathways across multiple tissues. In these studies the inhibitory molecules—most notably Smad7 and its interacting partners such as Arkadia, Smurf1/2, and YAP65—are shown to temper TGF‑β–driven responses that otherwise promote fibrosis, inflammation, apoptosis, and abnormal cellular proliferation in organs like the liver, kidney, heart, pancreas, and even the skin."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFor example, several reports demonstrate that robust up‐regulation of Smad7 in response to TGF‑β or BMP signals sets up a negative feedback loop capable of inhibiting downstream Smad2/3 phosphorylation. This in turn results in decreased transcription of fibrogenic and pro‑inflammatory mediators, thereby lessening progression of tissue fibrosis and ameliorating cellular apoptosis in experimental renal, cardiac, and pulmonary disease models."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional work has detailed how modulators of TGF‑β signaling not only control Smad phosphorylation but also intersect with other pathways (including NF‑κB, MAPK, and Wnt) to coordinate diverse cellular outcomes such as differentiation, proliferation, and survival. Mechanisms such as Arkadia‑mediated polyubiquitination of Smad7 and enhanced recruitment of inhibitory partners contribute to curbing excessive signal propagation—a concept that suggests the existence of parallel phosphatase‐based controls. Although Smad7 is the primary inhibitory signal transducer discussed in these reports, PPM1L belongs to the PP2C family of serine/threonine phosphatases and is known from the wider literature to dephosphorylate key signaling intermediates; accordingly, its putative function would be to similarly deactivate components of the TGF‑β cascade, thereby providing an additional layer of control."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn several experimental settings—including models of fibrotic renal injury, post‑infarction cardiac remodeling, and aberrant epithelial repair—disruption or overexpression of inhibitory molecules has been linked with dramatic changes in extracellular matrix deposition, inflammatory cell recruitment, and cell survival. Such findings underscore the importance of a tightly regulated balance between phosphorylation and dephosphorylation events in TGF‑β signaling. In this context, even though PPM1L is not explicitly mentioned, by analogy its enzymatic dephosphorylation activity could serve to withdraw active phosphorylated Smads or even receptor complexes from the signaling pool, thereby attenuating the profibrotic and pro‑inflammatory responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurthermore, insights from studies examining TGF‑β signaling in tumor suppression, immune regulation, and developmental processes (including skeletal myogenesis and intestinal homeostasis) reveal that modulation of signal duration and intensity is critical to prevent pathological outcomes. These investigations—although mainly focused on Smad7 and its partners—raise the possibility that phosphatases like PPM1L, as part of the broader negative regulatory machinery, could help restore cellular equilibrium by terminating signals once they have fulfilled their physiological roles."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurther evidence from studies focused on TGF‑β–driven pathological processes in diverse organs (from the kidney and liver to the gut and skeletal muscle) reinforces the concept that excessive or prolonged TGF‑β signaling leads to detrimental outcomes such as uncontrolled fibrosis and tumorigenesis. In these settings the inhibitory feedback provided by Smad7 is vital, and by extension, phosphatases like PPM1L are anticipated to contribute similarly by catalyzing dephosphorylation events that “switch off” active signaling. This termination of signaling is essential for restoring tissue homeostasis and preventing pathological remodeling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn summary, the collection of studies emphasizes that fine‑tuning the TGF‑β/Smad axis—via inhibitory components capable of blocking or reversing signal propagation—is critical for normal tissue repair, immunomodulation, and prevention of fibrosis and cancer. Although PPM1L is not directly evaluated in any of these abstracts, its membership in the PP2C phosphatase family implies a parallel role: dephosphorylating activated receptors or Smads to attenuate TGF‑β signaling. Such a function would be entirely consistent with the broader theme observed in these reports, and it supports the idea that PPM1L may serve as a natural “brake” on TGF‑β–mediated pathological processes, offering a potential therapeutic target in diseases marked by hyperactive TGF‑β signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "28", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Léon Kautz, Delphine Meynard, Annabelle Monnier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-03-143354"}], "href": "https://doi.org/10.1182/blood-2008-03-143354"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18539898"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18539898"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hui Y Lan, Wei Mu, Naruya Tomita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Soc Nephrol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.asn.0000067632.04658.b8"}], "href": "https://doi.org/10.1097/01.asn.0000067632.04658.b8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12761254"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12761254"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiangwei Xiao, Iljana Gaffar, Ping Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1321347111"}], "href": "https://doi.org/10.1073/pnas.1321347111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24639504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24639504"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Steven Dooley, Jafar Hamzavi, Loredana Ciuclan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2008.04.038"}], "href": "https://doi.org/10.1053/j.gastro.2008.04.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18602923"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18602923"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wansheng Wang, Xiao R Huang, Allen G Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Soc Nephrol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1681/ASN.2004121070"}], "href": "https://doi.org/10.1681/ASN.2004121070"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15788474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15788474"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hai Yong Chen, Xiao R Huang, Wansheng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db10-0403"}], "href": "https://doi.org/10.2337/db10-0403"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20980457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20980457"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Shinji Kume, Masakazu Haneda, Keizo Kanasaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M605904200"}], "href": "https://doi.org/10.1074/jbc.M605904200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17098745"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17098745"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Daizo Koinuma, Masahiko Shinozaki, Akiyoshi Komuro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/emboj/cdg632"}], "href": "https://doi.org/10.1093/emboj/cdg632"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14657019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14657019"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Olivier Ferrigno, François Lallemand, Franck Verrecchia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1205623"}], "href": "https://doi.org/10.1038/sj.onc.1205623"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12118366"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12118366"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Hirotaka Fukasawa, Tatsuo Yamamoto, Akashi Togawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0400035101"}], "href": "https://doi.org/10.1073/pnas.0400035101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15173588"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15173588"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Toru Fukuda, Masakazu Kohda, Kazuhiro Kanomata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M801681200"}], "href": "https://doi.org/10.1074/jbc.M801681200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18684712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18684712"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Arthur C K Chung, Xiao R Huang, Li Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nephrol Dial Transplant (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/ndt/gfn699"}], "href": "https://doi.org/10.1093/ndt/gfn699"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19096081"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19096081"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Xiao-Ming Meng, Xiao Ru Huang, Jun Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kidney Int (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ki.2011.327"}], "href": "https://doi.org/10.1038/ki.2011.327"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22048127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22048127"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Massimo C Fantini, Angelamaria Rizzo, Daniele Fina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2008.12.053"}], "href": "https://doi.org/10.1053/j.gastro.2008.12.053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19192480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19192480"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yoshiko Nagano, Konstantinos J Mavrakis, Kian Leong Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M701294200"}], "href": "https://doi.org/10.1074/jbc.M701294200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17510063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17510063"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Gangwen Han, Allen G Li, Yao-Yun Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smad7-induced beta-catenin degradation alters epidermal appendage development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Cell (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.devcel.2006.06.014"}], "href": "https://doi.org/10.1016/j.devcel.2006.06.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16950122"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16950122"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Marcello Arsura, Ganesh R Panta, Jennifer D Bilyeu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1206132"}], "href": "https://doi.org/10.1038/sj.onc.1206132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12545162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12545162"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Shizuya Saika, Kazuo Ikeda, Osamu Yamanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0002-9440(10)62358-9"}], "href": "https://doi.org/10.1016/S0002-9440(10"}, {"type": "t", "text": "62358-9) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15855641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15855641"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Nora G Smart, Asa A Apelqvist, Xueying Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.0040039"}], "href": "https://doi.org/10.1371/journal.pbio.0040039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16435884"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16435884"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "S M Ka, Y C Yeh, X R Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-011-2364-5"}], "href": "https://doi.org/10.1007/s00125-011-2364-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22086159"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22086159"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Hong-Lei Weng, Loredana Ciuclan, Yan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.21806"}], "href": "https://doi.org/10.1002/hep.21806"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17657819"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17657819"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Zhen Liu, Xiao Ru Huang, Hai-Yong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Invest (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/labinvest.2012.2"}], "href": "https://doi.org/10.1038/labinvest.2012.2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22330342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22330342"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Katarzyna Mleczko-Sanecka, Guillem Casanovas, Anan Ragab, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-09-238105"}], "href": "https://doi.org/10.1182/blood-2009-09-238105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20040761"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20040761"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Diptadip Dattaroy, Sahar Pourhoseini, Suvarthi Das, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00346.2014"}], "href": "https://doi.org/10.1152/ajpgi.00346.2014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25501551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25501551"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Guan-Xian Liu, You-Qi Li, Xiao R Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0053573"}], "href": "https://doi.org/10.1371/journal.pone.0053573"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23301086"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23301086"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Wei He, Allen G Li, Dongyan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/emboj/21.11.2580"}], "href": "https://doi.org/10.1093/emboj/21.11.2580"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12032071"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12032071"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Shinsuke Takagawa, Gabriella Lakos, Yasuji Mori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1523-1747.2003.12308.x"}], "href": "https://doi.org/10.1046/j.1523-1747.2003.12308.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12839562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12839562"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Masatoshi Ohgushi, Shunsuke Kuroki, Hiroshi Fukamachi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.25.22.10017-10028.2005"}], "href": "https://doi.org/10.1128/MCB.25.22.10017-10028.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16260615"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16260615"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Qian Chen, Hanying Chen, Dawei Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smad7 is required for the development and function of the heart."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M807233200"}], "href": "https://doi.org/10.1074/jbc.M807233200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18952608"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18952608"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Louise E Reynolds, Francesco J Conti, Rita Silva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "alpha3beta1 integrin-controlled Smad7 regulates reepithelialization during wound healing in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI33538"}], "href": "https://doi.org/10.1172/JCI33538"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18246199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18246199"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Miguel A Alejandre-Alcázar, Matthias Michiels-Corsten, Alfin G Vicencio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Dyn (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dvdy.21403"}], "href": "https://doi.org/10.1002/dvdy.21403"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18095342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18095342"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Satoko Saito, Hiroyuki Matsui, Miyuki Kawano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein phosphatase 2Cepsilon is an endoplasmic reticulum integral membrane protein that dephosphorylates the ceramide transport protein CERT to enhance its association with organelle membranes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M707691200"}], "href": "https://doi.org/10.1074/jbc.M707691200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18165232"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18165232"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Z Zhu, Y Xu, J Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2015.102"}], "href": "https://doi.org/10.1038/bjc.2015.102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25867271"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25867271"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Claudio Humeres, Arti V Shinde, Anis Hanna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI146926"}], "href": "https://doi.org/10.1172/JCI146926"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34905511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34905511"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Li-Hua Wei, Xiao-Ru Huang, Yang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cvr/cvt151"}], "href": "https://doi.org/10.1093/cvr/cvt151"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23761400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23761400"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Angelamaria Rizzo, Maximilian J Waldner, Carmine Stolfi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Smad7 expression in T cells prevents colitis-associated cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-11-1895"}], "href": "https://doi.org/10.1158/0008-5472.CAN-11-1895"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22028324"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22028324"}]}]}]}
|
| Synonyms | PP2C-EPSILON, PPM1-LIKE |
| Proteins | PPM1L_HUMAN |
| NCBI Gene ID | 151742 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PPM1L has 5,225 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 108 datasets.
Click the + buttons to view associations for PPM1L from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PPM1L gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PPM1L gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PPM1L gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PPM1L gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PPM1L gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PPM1L gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PPM1L gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PPM1L gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PPM1L gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PPM1L gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PPM1L protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PPM1L gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PPM1L gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PPM1L gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PPM1L protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PPM1L protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing PPM1L protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PPM1L protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PPM1L protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PPM1L gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PPM1L gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with PPM1L gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with PPM1L gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PPM1L protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PPM1L gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with PPM1L gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PPM1L gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PPM1L gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PPM1L gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PPM1L gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PPM1L gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PPM1L gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PPM1L gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PPM1L from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PPM1L gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PPM1L gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PPM1L from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PPM1L gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PPM1L gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PPM1L gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PPM1L gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PPM1L gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PPM1L gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PPM1L gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PPM1L gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PPM1L gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PPM1L protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing PPM1L protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing PPM1L protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PPM1L gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PPM1L gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PPM1L gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of PPM1L gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PPM1L gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PPM1L gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PPM1L gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with PPM1L gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PPM1L gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PPM1L gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PPM1L gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PPM1L gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PPM1L protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PPM1L gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PPM1L gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PPM1L protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PPM1L gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PPM1L from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PPM1L gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PPM1L protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PPM1L gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PPM1L gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PPM1L gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PPM1L gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PPM1L gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PPM1L gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PPM1L protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PPM1L gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PPM1L gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PPM1L gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PPM1L gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PPM1L gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PPM1L gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PPM1L from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PPM1L gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PPM1L gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PPM1L protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PPM1L protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving PPM1L protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PPM1L protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PPM1L gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PPM1L gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PPM1L gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PPM1L gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PPM1L gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with PPM1L protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PPM1L gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PPM1L gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PPM1L gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PPM1L gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PPM1L gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PPM1L protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PPM1L protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PPM1L protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PPM1L protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PPM1L protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PPM1L protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving PPM1L protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PPM1L protein from the WikiPathways Pathways 2024 dataset. | |